research report      name index      key word index      corresp.unit            Page in german      Imprint + Privacy Policy   

Third-party-funded project

Title:
SIV-associated vacuolar leukoencephalopathy: role of the dopaminergic system in the development of neurodegeneration

Project management at the University of Würzburg:

Participating scientists:

Abstract:
HIV infects the central nervous system and induces neurological deficiencies in a great proportion of HIV-patients. There is ample evidence that the dopaminergic system plays a major role in the pathogenesis of this disease. Using the infection of rhesus monkeys with simian immunodeficiency viruses (SIV) as animal model, we could demonstrate early abnormalities in neurotransmitter systems. Already few weeks after infection, we found decreased levels of dopamine, alterations in amino acid neurotransmitters and reduced activity of the enzyme choline-azetyl tranferase (ChAT). Treatment of the infected animals with dopaminergic drugs like selegiline or L-Dopa normalized dopamine levels and restored ChAT activity. However, close neuropathological investigation revealed that these dopaminergic therapies increased brain viral load and induced vacuolization of the gray matter in SIV-infected monkeys. In additional experiments, animals were treated with dopamine agonists and antagonists. We could demonstrate that the observed negative effects of the increased dopamine availability in SIV-infected animals is not caused by receptor-mediated mechanisms. Rather, oxidative stress induced by dopamine or its metabolites might be responsible. This is emphasized by our findings that dopamine activates HIV in vitro by oxidative mechanisms. Our results bear important consequences for targeted neuropharmacological treatment strategies of HIV-induced neurological disease.

Key words:
    HIV
    SIV
    Rhesus monkeys
    CNS
    dopamine
    microglia
    selegiline

Projekt period: from 01.1999 to 12.2001

Funding institution:
Bund

Publications: